WASHINGTON— AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on yesterday’s passage of FY 2020 appropriations bills H.R....

WASHINGTON—Today AARP released the findings of a nationwide poll that explores the priorities and concerns of a key group of voters that could help determine the 2020 presidential election and...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on today’s vote by the U.S. House of Representatives on H.R....

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement urging the U.S. House of Representatives to vote in support of...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to the patent protections for biologic drugs and...

WASHINGTON—AARP Senior Vice President for Government Affairs Bill Sweeney released the following statement calling on Congress to extend and make permanent the medical expense deduction before...

WASHINGTON—AARP is pleased to announce that the National Kidney Foundation (NKF) and the Johns Hopkins Armstrong Institute for Patient Safety and Quality are the winners of the 2019 AARP Quality...

WASHINGTON — Approximately 41 million unpaid family caregivers provided an estimated 34 billion hours of care — worth a staggering $470 billion — to their parents, spouses, partners, and...

WASHINGTON—Retail prices for 267 brand-name drugs commonly used by older adults surged by an average of 5.8% in 2018, more than twice the general inflation rate of 2.4%, according to new AARP...

WASHINGTON—AARP Senior Vice President for Government Affairs Bill Sweeney released the following statement on the approval by the United States House of Representatives of H.R. 4334, the Dignity...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on today’s markup of H.R. 3, the Lower Drug Costs Now Act of...

WASHINGTON—Today, AARP National Volunteer President Catherine Alicia Georges, EdD, RN, testified at the U.S. House Ways and Means Committee hearing on “Investing in the U.S. Health System by...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement today, applauding the introduction of legislation in the U.S....

WASHINGTON—A new AARP Public Policy Institute report, released today, shows that retail prices for a combined set of 754 widely used brand name, generic, and specialty prescription drugs...

CHICAGO—AARP today released new data and an infographic illustrating the impact of high prescription drug prices on Americans, specifically people living with cancer, prediabetes or diabetes,...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today after the administration announced a Notice of Proposed...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today, applauding the Senate Finance Committee’s 19-9 bipartisan...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today in support of Sen. Debbie Stabenow’s amendment on...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today, responding to the Senate Finance Committee (SFC)...

WASHINGTON—AARP released today its "AARP Asks the Candidates" video series featuring 17 presidential candidates and their plans to address high prescription drug prices, Medicare and Social...

WASHINGTON—Today, AARP announced the largest group of AARP Community Challenge grantees to date. AARP will distribute nearly $1.6 million among 159 grant winners developing “quick-action”...

WASHINGTON—AARP Foundation and the law firm of Garrison, Levin-Epstein, Fitzgerald & Pirrotti, P.C., filed a class action lawsuit on behalf of Yale University employees today, alleging that...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to today’s federal court ruling on the U.S....

WASHINGTON—The prices of widely used specialty prescription drugs grew more than three times faster than general inflation in 2017, according to a new AARP Public Policy Institute report...

WASHINGTON — AARP released the following statement on President Trump’s new executive order requiring doctors, hospitals, and insurers to disclose more information about health care costs. The...